Our latest news. Find out what’s new in research and treatments. See what you’ve been doing to lend your support. Be the first to see how your support is making a difference.
Leading charities Children with Cancer UK and Cancer Research UK will co-fund a major £5.5 million research programme to advance precision medicine for children and young people whose cancer has returned.Find out more
A young cancer patient from Birmingham is supporting a brand new campaign to help raise awareness during Childhood Cancer Awareness Month this September. The charity’s new ‘give a hug’ campaign highlights the importance of this simple gesture. Whether it’s from friends or family, a big squeeze or a small cuddle, the charity’s moving campaign film shows how this wordless gesture can say so much.Find out more
Children with Cancer UK, has announced ‘The Really Big Auction’ offering once-in-a-lifetime prizes including VIP concert tickets to Rod Stewart in Las Vegas, lunch with the stars of Downton Abbey and a Sunday roast with the cast of Eastenders.Find out how you can help
Our #film follows Billy and Demi – two childhood cancer survivors and their families, on a journey of precious highs, painful lows – and all the moments in between that became so meaningful. Because for children with cancer, every single moment is a milestone.Find out more
Children and young people living with cancer from across the West Midlands, Oxfordshire and parts of Southern England will now benefit from improved genetic testing, thanks to a seven-figure donation to Birmingham Children’s Hospital Charity from Children with Cancer UK, in partnership with Kwik-Fit.Read more
We’re funding new research, led by Professor Tariq Enver, a world leader in the field of leukaemia.
Current treatments for children with acute lymphoblastic leukaemia (ALL) are highly toxic meaning children may suffer long term side effects.
This project aims to develop more targeted and less toxic therapies which will reduce the toxic effects on the rest of the body.Find out more
Targeted drugs used for the treatment of breast and ovarian cancer in women could provide a novel treatment in osteosarcoma
Scientists at UCL have found that a mutation commonly seen in osteosarcomas, the most common type of bone cancer, could render tumours susceptible to a licensed group of cancer treatments known as PARP inhibitors.Find out more